{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:00:02Z","timestamp":1793642402343,"version":"4.5.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is a rare, yet treatable, disorder of fatty acid \u03b2-oxidation with clinical presentations ranging from neonatal to very-late-onset forms. Very-late-onset MADD often has no identifiable genetic mutations and has been linked to sertraline exposure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We report a case of very late-onset MADD with negative genetic testing, potentially associated with sertraline use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A 75-year-old woman presented with 3-year history of progressive, proximal-predominant weakness, dysphagia, and dysarthria. Examination revealed severe axial and proximal-predominant limb weakness. Laboratory studies showed elevation of multiple acylcarnitines. Muscle biopsy demonstrated a lipid storage myopathy. Comprehensive genetic testing was negative. Sertraline use was identified as a potential trigger. Treatment with riboflavin, coenzyme Q10, and levocarnitine, along with discontinuation of sertraline, led to rapid clinical improvement within weeks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>This case supports the recent findings that sertraline can be associated with very-late-onset MADD. Neurologists should maintain a high index of suspicion for MADD in sertraline-treated patients with unexplained weakness because prompt initiation of riboflavin is crucial for strength recovery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0000000000000528","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T18:01:40Z","timestamp":1756922500000},"page":"14-17","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Very-Late Onset Multiple Acyl-Coenzyme A Dehydrogenase Deficiency Associated With Sertraline Use: A Case Report"],"prefix":"10.1097","volume":"27","author":[{"given":"Allison R.","family":"Valerius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thapat","family":"Wannarong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafid","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerin","family":"Liewluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"R1-20250905","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/humu.10226","article-title":"Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency","volume":"22","author":"Olsen","year":"2003","journal-title":"Hum Mutat"},{"key":"R2-20250905","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00641-0","article-title":"COASY variant as a new genetic cause of riboflavin-responsive lipid storage myopathy","volume":"10","author":"Zheng","year":"2024","journal-title":"Cell Discov"},{"key":"R3-20250905","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nmd.2021.01.006","article-title":"A systematic review of late-onset and very-late-onset multiple acyl-coenzyme A dehydrogenase deficiency: cohort analysis and patient report from Taiwan","volume":"31","author":"Kuo","year":"2021","journal-title":"Neuromuscul Disord NMD"},{"key":"R4-20250905","doi-asserted-by":"crossref","first-page":"105899","DOI":"10.1016\/j.biocel.2020.105899","article-title":"Disorders of flavin adenine dinucleotide metabolism: MADD and related deficiencies","volume":"132","author":"Mereis","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"key":"R5-20250905","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CM9.0000000000000032","article-title":"Clinical and muscle magnetic resonance image findings in patients with late-onset multiple acyl-CoA dehydrogenase deficiency","volume":"132","author":"Hong","year":"2019","journal-title":"Chin Med J"},{"key":"R6-20250905","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.27030","article-title":"Multiple acyl-coenzyme A dehydrogenase deficiency is associated with sertraline use - is there an acquired form?","volume":"96","author":"Sunebo","year":"2024","journal-title":"Ann Neurol"},{"key":"R7-20250905","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0960-8966(91)90097-C","article-title":"Late onset lipid storage myopathy due to multiple acyl CoA dehydrogenase deficiency triggered by valproate","volume":"1","author":"Papadimitriou","year":"1991","journal-title":"Neuromuscul Disord"},{"key":"R8-20250905","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12883-021-02121-y","article-title":"Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Neurol"},{"key":"R9-20250905","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00401-024-02830-x","article-title":"Lipid storage myopathy associated with sertraline treatment is an acquired mitochondrial disorder with respiratory chain deficiency","volume":"148","author":"Hedberg-Oldfors","year":"2024","journal-title":"Acta Neuropathol"},{"key":"R10-20250905","doi-asserted-by":"crossref","first-page":"105213","DOI":"10.1016\/j.nmd.2024.105213","article-title":"Very-late-onset multiple Acyl-coenzyme a dehydrogenase deficiency with elevated GDF-15 and Aldolase: a case report","volume":"45","author":"Gaini","year":"2024","journal-title":"Neuromuscul Disord"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:00:16Z","timestamp":1757106016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000528","relation":{},"ISSN":["1522-0443","1537-1611"],"issn-type":[{"value":"1522-0443","type":"print"},{"value":"1537-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}